Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$26K Sell
207
-30
-13% -$3.91K ﹤0.01% 735
2025
Q3
$34.7K Buy
237
+5
+2% +$756 0.01% 666
2025
Q2
$36.9K Buy
232
+84
+57% +$13.3K 0.01% 616
2025
Q1
$24K Sell
148
-369
-71% -$61.4K 0.01% 632
2024
Q4
$84.4K Buy
517
+2
+0.4% +$358 0.01% 459
2024
Q3
$101K Sell
515
-1,664
-76% -$307K 0.02% 380
2024
Q2
$376K Buy
2,179
+2,071
+1,918% +$345K 0.05% 289
2024
Q1
$18.1K Sell
108
-1,012
-90% -$190K 0.03% 226
2023
Q4
$221K Buy
1,120
+77
+7% +$13.6K 0.04% 279
2023
Q3
$182K Sell
1,043
-31
-3% -$5.63K 0.05% 295
2023
Q2
$185K Buy
+1,074
New +$186K 0.03% 391

Other funds holding ZTS

ORG Partners's ZTS Position: Q4 2025 in Review

ORG Partners reduced its Zoetis (ZTS) stake by 13% in Q4 2025, selling an estimated $3.91K and leaving 207 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #735.

ORG Partners first reported a position in ZTS in Q2 2023 and has held it in 11 quarters since. The position peaked at $376K in Q2 2024. 1,683 funds tracked by Wall St. Rank hold ZTS as of Q4 2025.

  • ORG Partners held 207 shares of Zoetis worth $26K as of Q4 2025.
  • ORG Partners sold 30 Zoetis shares in Q4 2025, an estimated $3.91K.
  • Zoetis made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #735 holding.
  • ORG Partners first reported a position in Zoetis in Q2 2023 and has held it in 11 quarters since.
  • ORG Partners's Zoetis position peaked at $376K in Q2 2024.
  • 1,683 funds tracked by Wall St. Rank held Zoetis as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.